Clinical Trial Update: Single Dose Escalation Study of CM383 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 single-dose escalation study of CM383 in healthy volunteers is currently recruiting for testing safety and pharmacokinetics, in the context of Alzheimer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• CM383

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Alzheimer Disease | Phase 1 | Status: RECRUITING